![](assets_2023/img/relations_bg_top.png)
Captor Therapeutics ®
News
![miniatura](https://captortherapeutics.com/userfiles/news/25-1684392745_thumb.jpg)
March 15, 2021
Captor Therapeutics S.A. is set to conduct a public offering
![miniatura](https://captortherapeutics.com/userfiles/news/24-1684228477_thumb.png)
March 01, 2021
Paweł Dobrzański, PhD, joins Captor Therapeutics S.A. as Biology Department Director
![miniatura](https://captortherapeutics.com/userfiles/news/22-1684228500_thumb.png)
January 20, 2021
Tom Shepherd as Chief Executive Officer
![miniatura](https://captortherapeutics.com/userfiles/news/21-1684392763_thumb.jpg)
December 22, 2020
Captor Therapeutics and Sosei Heptares Enter Strategic Collaboration
![miniatura](https://captortherapeutics.com/userfiles/news/20-1684228520_thumb.jpg)
October 22, 2020
Captor Therapeutics as one of the „Scrip’s 10 To Watch”
![miniatura](https://captortherapeutics.com/userfiles/news/18-1684228529_thumb.jpg)
April 24, 2020
A new project in the area of autoimmune diseases
![miniatura](https://captortherapeutics.com/userfiles/news/17-1684228540_thumb.jpg)
March 05, 2020
Advancing the technological platform
![miniatura](https://captortherapeutics.com/userfiles/news/19-1684228550_thumb.png)
February 21, 2020
Captor's review article